-
Mashup Score: 0
“These are without doubt some of the most serious abuses we have uncovered in recent years,” said U.K. antitrust regulator Andrea Coscelli.
Source: STATCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1The relationship between adrenocortical candidate gene expression and clinical response to hydrocortisone in patients with septic shock - PubMed - 3 year(s) ago
In patients with septic shock, there is no association between adrenocortical candidate gene expression and mortality. Patients with higher expression of GLCCI1 who received hydrocortisone achieved shock resolution faster than those receiving placebo; conversely, patients who had higher expression o …
Source: PubMedCategories: Critical Care, Latest HeadlinesTweet-
The relationship between #adrenocortical #candidate #gene #expression and clinical response to #hydrocortisone in patients with #septic #shock #IntensiveCare #ICU https://t.co/d50WU3GY40 https://t.co/rRRsKlppNb
-
-
Mashup Score: 0Machine Learning Estimates Treatment Effect of Corticosteroids in Septic Shock - Infectious Disease Advisor - 3 year(s) ago
Evidence shows a positive net benefit from an individualized treatment strategy deciding which septic shock patients to treat with corticosteroids.
Source: Infectious Disease AdvisorCategories: Infectious Disease, Latest HeadlinesTweet-
Corticosteroids, either #hydrocortisone or hydrocortisone plus fludrocortisone, decreased risk of 90-day mortality compared with placebo or usual care. https://t.co/Mul539Nf7T
-
-
Mashup Score: 7Effect of Hydrocortisone on Mortality or Respiratory Support Among Critically Ill COVID-19 Patients - 4 year(s) ago
This randomized clinical trial compares the effect of low-dose hydrocortisone vs placebo on treatment failure (death or persistent respiratory support dependency) at 21 days in critically ill patients with COVID-19 and acute respiratory failure in France.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
In this RCT, low-dose #hydrocortisone didn't reduce death or persistent respiratory support at day 21 vs placebo among critically ill pts w #COVID19 & respiratory failure; study was stopped early when RECOVERY trial findings were announced https://t.co/0HuM0WYZU8 #VisualAbstract
-
-
Mashup Score: 3Hydrocortisone Did Not Reduce Mortality, Respiratory Support Need in COVID-19 - Infectious Disease Advisor - 4 year(s) ago
By day 21, hydrocortisone was not associated with a significant reduction in the need for respiratory support in critically ill patients with COVID-19.
Source: Infectious Disease AdvisorCategories: Infectious Disease, Latest HeadlinesTweet-
Low-dose #hydrocortisone was not associated with a significant reduction in death by day 21 of treatment compared with placebo in critically ill patients with COVID-19. https://t.co/t5eldZZ5sL
-
-
Mashup Score: 0Hydrocortisone Did Not Reduce Mortality, Respiratory Support Need in COVID-19 - Pulmonology Advisor - 4 year(s) ago
By day 21, hydrocortisone was not associated with a significant reduction in the need for respiratory support in critically ill patients with COVID-19.
Source: Pulmonology AdvisorCategories: Latest Headlines, PulmonologyTweet-
Low-dose #hydrocortisone was not associated with a significant reduction in death or need for persistent #respiratorysupport by day 21 of treatment compared with placebo in #criticallyill patients with #COVID-19. #Pulmonology Read More: https://t.co/BkLUOccDRA
-
-
Mashup Score: 0Leopard skin - 4 year(s) ago
A 58-year-old woman presented with fever and fatigue for the past 4 weeks. She reported hyperpigmented lesions on her arms and face on a background of mostly hypopigmented skin, creating a leopard-like appearance (figure A). The lesions first appeared 9 months earlier, and the dark pigment intensified over time. Her history included vitiligo and primary adrenal insufficiency, for which she…
Categories: Endocrinology, Latest HeadlinesTweet-
Clinical Picture: Leopard skin https://t.co/9kzhMT8l80 #hydrocortisone #adrenal insufficiency #vitiligo
-
-
Mashup Score: 1Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 - 4 year(s) ago
This open-label randomized trial compares the effects of fixed-dose vs shock-dependent vs no intravenous hydrocortisone on organ support–free days among patients with coronavirus disease 2019 (COVID-19) admitted to critical care units (ICU/CCUs) for respiratory or cardiovascular organ support.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Enhance your #eISICEM2020 experience with the @remap_cap trial on #hydrocortisone and mortality and organ support among patients with severe #COVID19 https://t.co/Sqhp6FIUUK
-
-
Mashup Score: 8Corticosteroids for COVID-19: New Evidence of Benefit - 4 year(s) ago
A conversation with Jonathan A. C. Sterne, MA, MSc, PhD, of the University of Bristol, Todd W. Rice, MD, MSc, of Vanderbilt University, and Janet V. Diaz, MD, of the World Health Organization (WHO) on the latest research supporting the use of hydrocortisone and dexamethasone for treatment of COVID-19 ARDS. Recorded September 2, 2020.
Source: edhub.ama-assn.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Jonathan A C Sterne, MA, MSc, PhD, of @BristolUni, Todd W Rice, MD, MSc, of @VanderbiltU, and Janet V Diaz, MD, of @WHO discuss the latest research supporting the use of #hydrocortisone and #dexamethasone for treatment of #COVID19 #ARDS https://t.co/A92GrftTG7
-
-
Mashup Score: 7Corticosteroids for COVID-19: New Evidence of Benefit - 4 year(s) ago
A conversation with Jonathan A. C. Sterne, MA, MSc, PhD, of the University of Bristol, Todd W. Rice, MD, MSc, of Vanderbilt University, and Janet V. Diaz, MD, of the World Health Organization (WHO) on the latest research supporting the use of hydrocortisone and dexamethasone for treatment of COVID-19 ARDS. Recorded September 2, 2020.
Source: edhub.ama-assn.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Jonathan A C Sterne, MA, MSc, PhD, of @BristolUni, Todd W Rice, MD, MSc, of @VanderbiltU, and Janet V Diaz, MD, of @WHO discuss the latest research supporting the use of #hydrocortisone and #dexamethasone for treatment of #COVID19 #ARDS https://t.co/z1B9jb0mmQ
-
U.K. issues record fine to drug makers for price gouging and collusion schemes.. https://t.co/8c8USlXp1U #pharma #pricegouing #antitrust #hydrocortisone $TEVA $ABBV